Empowering innovation, driving investment, and facilitating partnering

Unique sector insights from industry leaders to transform your business

More senior, more investment power, more opportunity

The LSX World Congress is Europe’s leading partnering, strategy, and investment event, with qualified 1:1 partnering at its core.

We gather senior life science industry decision-makers from the world’s most innovative biopharma, medtech and healthtech companies with investors, senior BD&L teams, R&D leaders and industry KOLs.

Together, they share best practices, forge partnerships, and discuss investment – to revolutionise healthcare.

Join CIC’s Anne Horgan, a panellist as part of the Biotech Startup CEO Forum, on 28 April:

From Concept to Commercialisation: Overcoming the Challenges of Early-Stage Biotech Startups

Biotech startups are at the forefront of innovation, turning cutting-edge research into life-changing therapies. However, the transition from an idea to a fully-fledged startup presents a range of challenges, from securing initial funding to establishing a solid R&D foundation and crafting a compelling business model. Attendees will gain insights into attracting seed capital, building strong teams, and forming strategic partnerships that can accelerate growth and increase the likelihood of long-term success.

  • Effective approaches for securing early-stage investment, including pitching to investors and utilizing non-dilutive funding options
  • Creating a compelling narrative to clearly communicate your startup’s value proposition and market potential
  • Expert advice for early-stage entrepreneurs on the key actions to take today for future success